Posts In: Gubba Pharma In E News

Enzene opens its first continuous biologics manufacturing facility

November 14, 2019 Gubba Pharma In E News

Enzene Biosciences, a subsidiary of Alkem Laboratories, has formally opened its first fully connected continuous Biologics manufacturing facility in Pune. This first-of-its-kind facility was built...

Continue Reading

Govt gives go-ahead for 4 medical device parks

November 14, 2019 Gubba Pharma In E News

The government has given approval for setting up four medical device parks with a view to support Make in India initiative and provide world-class products...

Continue Reading

Regulator waives off clinical trials, clears Sanofi TB drug

November 6, 2019 Gubba Pharma In E News

India’s drug regulator has approved (India)’s new anti-tuberculosis drug rifapentine , waiving local clinical trials in a move to bolster efforts to prevent latent infections...

Continue Reading

J&J unveils next-gen monofocal intraocular lens in India

November 6, 2019 Gubba Pharma In E News

In an endeavour recognizing the need to provide solutions to post-operative cataract patients to enhance vision, Johnson & Johnson Vision, a global leader in eye...

Continue Reading

Drug Manufacturing: Implications of the U.S. – E.U. Mutual Recognition Agreement

November 6, 2019 Gubba Pharma In E News

the United States and European Union finalized a Mutual Recognition Agreement (MRA) for drug manufacturing inspections. Both parties have now fully implemented the MRA for...

Continue Reading

Prospective Need For: Vegetable Seed Storage

October 31, 2019 ., Gubba Pharma In E News

India is the second-largest producer of fresh fruits and vegetables. Unfortunately, due to the lack of knowledge and facility, the country ends up wasting almost...

Continue Reading

INTENTIONS AND OMISSIONS IN HEALTH CARE

October 30, 2019 Gubba Pharma In E News

For being born as Human being all through my professional years, I relished the journey of my life from where I was once to be...

Continue Reading

GSK’s SAM technology could revolutionise vaccines

October 30, 2019 Gubba Pharma In E News

At GSK, we work on vaccines aiming to help combat devastating infectious diseases like malaria, tuberculosis, HSV, RSV and COPD. Jeff Ulmer, Head Preclinical R&D...

Continue Reading

Biocon’s biologics portfolio comes into its own

October 30, 2019 Gubba Pharma In E News

Five years ago, Biocon’s biologics business largely consisted of insulin clones and was worth about ₹400 crore. At the time, Biocon was valued at just...

Continue Reading